Mayo ClinicMayo Clinic Jacksonville 4500 San Pablo Rd S, Jacksonville, FL 32224 904-953-2000 (phone), 904-953-2898 (fax)
Education:
Medical School University of Puerto Rico School of Medicine Graduated: 1979
Procedures:
Chemotherapy
Conditions:
Malignant Neoplasm of Female Breast
Languages:
English
Description:
Dr. Perez graduated from the University of Puerto Rico School of Medicine in 1979. She works in Jacksonville, FL and specializes in Hematology/Oncology. Dr. Perez is affiliated with Mayo Clinic.
Latham & Watkins LLP 633 West Fifth Street Suite 4000, Los Angeles, CA 90071 213-485-1234 (Office), 213-891-8763 (Fax)
Licenses:
California - Active 1982
Education:
University of California at Berkeley, Boalt Hall School of Law Degree - JD - Juris Doctor - Law Graduated - 1980 University of California - Davis Degree - BA - Bachelor of Arts Graduated - 1976
Specialties:
Real Estate - 34% Land Use / Zoning - 33% Native Peoples Law - 33%
Heart safety was rated good for both groups of patients. And there was no difference in the rate of cancer spreading from the breast to the brain, study co-chair Dr. Edith Perez, director of the Breast Cancer Translational Genomics Program at the Mayo Clinic in Florida, said in a Mayo news release.
Date: Sep 30, 2014
Category: Health
Source: Google
Life expectancy rises in trial of new breast cancer drug
Two experts not involved in the study, Dr. Edith Perez of the Mayo Clinic in Jacksonville, Fla., and Dr. Harold Burstein of the Dana-Farber Cancer Institute in Boston, said the results were impressive.
Date: Sep 28, 2014
Category: Health
Source: Google
Another step in fight against HER2-positive breast cancer
benefit from Herceptin, nor how much the test will cost patients. But lead author Dr. Edith Perez, of Mayo's Jacksonville, Fla., campus, was quoted by Mayo as saying "we are on our way to developing a predictive test that can define the right treatment for individual patients, and that is very exciting.
Date: Dec 08, 2012
Category: Health
Source: Google
Another boost for Novartis' Afinitor in breast cancer
side effects. "In spite of the toxicity, this is the first time that we see such a degree of delay of tumor progression in women with refractory estrogen receptor positive breast cancer," said Mayo Clinic's Edith Perez, who headed up the independent panel monitoring the trial (as quoted by Bloomberg).
"The magnitude of the impact seen in these trials is sufficient enough to incorporate the medicines in day-to-day practice," said Edith Perez, deputy director of the Mayo Clinic Comprehensive Cancer Center in Jacksonville, Fla., who wasn't directly involved in the studies.
Date: Dec 07, 2011
Category: Health
Source: Google
Roche, Novartis Cancer Drugs Delay Breast Tumor Progression
The main issue for the world is cost, said Edith Perez, deputy director of the Mayo Clinics cancer center in Jacksonville, Florida, in an interview. I hope pertuzumab is priced at a level that would allow prompt incorporation into the treatment regimen so patients can benefit.
Special guests include two 2011 Florida Times-Union EVE Award recipients, Edith Perez, an internationally recognized breast cancer physician, specialist and researcher at Mayo Clinic in Florida and Jeri Millard, a breast cancer survivor and owner of In the Pink, a non-profit boutique and salon for
Date: Sep 30, 2011
Source: Google
ASCO: Exemestane May Change Practice in Breast Ca Prevention
Safety may also give exemestane the edge over tamoxifen, making the aromatase inhibitor actually the preferred agent for primary prevention, according to Edith Perez, MD, director of the breast program at the Mayo Clinic in Jacksonville, Fla.